ERBB2 Gene Complete Identifier and Functional Mapping Reference

Provide a comprehensive cross-database identifier and functional mapping reference for human ERBB2. This should serve as a definitive lookup resource …

Provide a comprehensive cross-database identifier and functional mapping reference for human ERBB2. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section

Structured Data Sources

This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 35 biological databases.

Further analyze this answer or run your own queries with BioBTree MCP.

Datasets: alphafold, alphamissense, bgee, bindingdb, ccds, chembl_molecule, chembl_target, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, intact, interpro, mim, orphanet, ortholog, pdb, pharmgkb_gene, reactome, refseq, scxa, signor, spliceai, string_interaction, transcript, ufeature, uniprot
Generated: 2026-03-27 — For the latest data, query BioBTree directly via MCP or API.
View API calls (44)
ERBB2

ERBB2 Cross-Database Identifier & Functional Mapping Reference Overview Gene Name: erb-b2 receptor tyrosine kinase 2 Symbol: ERBB2 Aliases: HER2, HER-2, NEU, CD340, c-ERB2, c-ERB-2, MLN-19, NGL, p185(erbB2)


Section 1: Gene Identifiers

DatabaseIdentifierNotes
HGNCHGNC:3430Approved symbol: ERBB2
Ensembl GeneENSG00000141736GRCh38
NCBI Entrez Gene2064
OMIM Gene/Locus164870Gene entry
Genomic Location (GRCh38/hg38)
AttributeValue
Chromosome17
Cytogenetic band17q12
Start position39,687,914
End position39,730,426
Strand+ (forward)
Genomic AccessionNC_000017.11

Section 2: Transcript Identifiers Ensembl Transcripts (Total: 34)

Transcript IDBiotypeStartEndUTR5UTR3
ENST00000269571protein_coding397000643972865839700064-3970023839728045-39728658
ENST00000445658protein_coding396997403972807939699740-3970023839728045-39728079
ENST00000578199protein_coding396881193971765739706990-3970700639717485-39717657
ENST00000578373nonsense_mediated_decay3970008039728577--
ENST00000578502protein_coding397000643972865839700064-3970023839728045-39728658
ENST00000578630retained_intron3971697439723968--
ENST00000578709protein_coding397031943970849239706990-39707006-
ENST00000580074protein_coding3971742939725203--
ENST00000582648nonsense_mediated_decay3970007439716311--
ENST00000582788retained_intron3970007439717655--
ENST00000582818protein_coding3971655139723950--
ENST00000583038retained_intron3970740439726351--
ENST00000583391retained_intron3970924439710410--
ENST00000584014protein_coding396881013971765739706990-3970700639717485-39717657
ENST00000584099protein_coding_CDS_not_defined3970674939709385--
ENST00000584450protein_coding397000243972804439700024-3970023839727698-39728044
ENST00000584601protein_coding396879143972836139706990-3970700639728045-39728361
ENST00000584684retained_intron3971734339720297--
ENST00000584888protein_coding_CDS_not_defined3972838639730426--
ENST00000584908retained_intron3970022739712330--
ENST00000863095protein_coding396999883972871439699988-3970023839728045-39728714
ENST00000863096protein_coding396999363972865839699936-3970023839728045-39728658
ENST00000863097protein_coding396999473972866239699947-3970023839728045-39728662
ENST00000863098protein_coding396999763972866139699976-3970023839728045-39728661
ENST00000863099protein_coding397000103972865239700010-3970023839728045-39728652
ENST00000863100protein_coding397000643972865839700064-3970023839728045-39728658
ENST00000863101protein_coding397000653972865639700065-3970023839728045-39728656
ENST00000863102protein_coding396999923972857739699992-3970023839728045-39728577
ENST00000863103protein_coding397000143972857739700014-3970023839728045-39728577
ENST00000938923protein_coding397000213972865839700021-3970023839728045-39728658
ENST00000938924protein_coding397000653972865739700065-3970023839728045-39728657
ENST00000938925protein_coding397000653972857739700065-3970023839728045-39728577
ENST00000959774protein_coding396999913972865239699991-3970023839728045-39728652
ENST00000959775protein_coding396999783972857739699978-3970023839728045-39728577
Biotype Summary: 25 protein_coding, 2 nonsense_mediated_decay, 6 retained_intron, 2 protein_coding_CDS_not_defined RefSeq Transcripts - Human mRNA (NM_) Accessions
RefSeq IDStatusMANE Select
NM_004448REVIEWED✓ YES (Canonical)
NM_001005862REVIEWED
NM_001289936REVIEWED
NM_001289937REVIEWED
NM_001289938REVIEWED
NM_001382782-NM_001382806REVIEWED(25 additional isoforms)
Total Human RefSeq mRNA Transcripts: 31 CCDS IDs (Consensus Coding Sequence)
CCDS ID
CCDS32642
CCDS45667
CCDS74052
CCDS77016
CCDS77017
CCDS92296
Total CCDS: 6 Exons for Canonical Transcript (ENST00000269571) Total Exon Count: 27
Exon IDStartEndStrand
ENSE000039099033970006439700311+
ENSE000034744393970699039707141+
ENSE000036531823970832139708534+
ENSE000036484523970931839709452+
ENSE000036637823970981339709881+
ENSE000036050993971008639710201+
ENSE000036794023971034039710481+
ENSE000035727933971192839712047+
ENSE000036101053971232239712448+
ENSE000035306643971528639715359+
ENSE000035232943971544639715536+
ENSE000036255643971574039715939+
ENSE000035649653971630139716433+
ENSE000036756343971651539716605+
ENSE000036321673971732039717480+
ENSE000036298883971978739719834+
ENSE000035913803972331939723457+
ENSE000036557543972353839723660+
ENSE000036292753972391239724010+
ENSE000036256003972472639724911+
ENSE000036570833972504939725204+
ENSE000035804763972532739725402+
ENSE000036501033972570739725853+
ENSE000034654383972656239726659+
ENSE000035850583972681539727003+
ENSE000035289933972729539727547+
ENSE000039075463972768939728658+

Section 3: Protein Identifiers UniProt Accessions (Total: 11)

AccessionNameStatusCanonical
P04626Receptor tyrosine-protein kinase erbB-2Reviewed (Swiss-Prot)✓ YES
B4DTR1Unreviewed
F5H1T4Unreviewed
J3KRI9Unreviewed
J3KTI5Unreviewed
J3QL83Unreviewed
J3QLU9Unreviewed
J3QLV2Unreviewed
J3QRJ7Unreviewed
J3QRX1Unreviewed
X5DNK3Unreviewed
Canonical Protein Properties (P04626):
  • Length: 1,255 amino acids
  • Mass: 137,910 Da
  • Alternative names: Metastatic lymph node gene 19 protein, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2 RefSeq Protein Accessions (Human NP_)
RefSeq IDStatusMANE Select
NP_004439REVIEWED✓ YES
NP_001005862REVIEWED
NP_001276865-NP_001276867REVIEWED
NP_001369711-NP_001369735REVIEWED(25 isoforms)
Total Human RefSeq Proteins: 31 Protein Domains and Families (InterPro) Total Domains/Families: 15
InterPro IDNameType
IPR000494Rcpt_L-domDomain
IPR000719Prot_kinase_domDomain
IPR001245Ser-Thr/Tyr_kinase_cat_domDomain
IPR006211Furin-like_Cys-rich_domDomain
IPR006212Furin_repeatRepeat
IPR008266Tyr_kinase_ASActive_site
IPR009030Growth_fac_rcpt_cys_sfHomologous_superfamily
IPR011009Kinase-like_dom_sfHomologous_superfamily
IPR016245Tyr_kinase_EGF/ERB/XmrK_rcptFamily
IPR017441Protein_kinase_ATP_BSBinding_site
IPR020635Tyr_kinase_cat_domDomain
IPR032778GF_recep_IVDomain
IPR036941Rcpt_L-dom_sfHomologous_superfamily
IPR049328TM_ErbB1Domain
IPR050122RTKFamily

Section 4: Structure Identifiers Experimental Structures (PDB) Total PDB Structures: 61

PDB IDMethodResolution (Å)Title
1MFGX-RAY1.25ERBIN PDZ domain with ErbB2 C-terminal tail
1MFLX-RAY1.88ERBIN PDZ domain with ErbB2 C-terminal tail
1MW4NMR-Grb7-SH2 domain with pY1139 peptide
1N8ZX-RAY2.52HER2 ECD with Herceptin Fab
1QR1X-RAY2.40HER-2/NEU epitope bound to HLA-A2.1
1S78X-RAY3.25ErbB2-pertuzumab complex
2A91X-RAY2.50ErbB2 domains 1-3
2JWANMR-ErbB2 transmembrane segment dimer
2KS1NMR-ErbB1/ErbB2 TM heterodimer
2L4KNMR-Grb7-SH2 with pY1139 peptide
2N2ANMR-HER2/ErbB2 dimeric TM domain
3BE1X-RAY2.90Dual specific bH1 Fab with HER2 ECD
3H3BX-RAY2.45scFv chA21 with ErbB2 ECD (1-192)
3MZWX-RAY2.90HER2 ECD with affibody ZHER2:342
3N85X-RAY3.20HER2 ECD trimer with antibody fragment
3PP0X-RAY2.25HER2 kinase domain
3RCDX-RAY3.21HER2 kinase with TAK-285
3WLWX-RAY3.09ErbB2 ECD homodimer
3WSQX-RAY3.50HER2 with Fab
4GFUX-RAY2.00PTPN18 with HER2-pY1248 peptide
4HRLX-RAY2.55HER2 ECD with designed protein
4HRMX-RAY3.20HER2 ECD with designed protein
4HRNX-RAY2.65HER2 ECD with designed protein
4NNDX-RAY2.50PTPN18 fingerprint on HER2 pY sites
5K33X-RAY3.30HER2 ECD with Fcab STAB19
5KWGX-RAY4.30HER2 ECD with Fcab H10-03-6
5MY6X-RAY2.25HER2 with nanobody
5O4GX-RAY3.00HER2 with Fab MF3958
5OB4NMR-HER2 TM domain dimer in DPC micelles
5TQSX-RAY1.88PLC-gamma1 SH2 with ErbB2 phosphopeptide
6ATTX-RAY3.7739S Fab bound to HER2 ECD
6BGTX-RAY2.70Trastuzumab Fab mutant with Her2 ECD
6J71X-RAY2.92HuA21-scFv with HER2 ECD
6LBXX-RAY2.03HER2 Domain IV with Rb-H2
6OGECryo-EM4.36HER2 ECD-Trastuzumab-Pertuzumab
7JXHX-RAY3.27HER2 with JBJ-08-178-01
7MN5Cryo-EM2.93HER2/HER3/NRG1b heterodimer ECD
7MN6Cryo-EM3.09HER2 S310F/HER3/NRG1b heterodimer
7MN8Cryo-EM3.45HER2/HER3/NRG1b with Trastuzumab Fab
7PCDX-RAY1.77HER2 with covalent inhibitor
7QVKX-RAY3.10NM-02 with HER2 ECD
8FFJCryo-EM7.50Zanidatamab bound to HER2
8HGOCryo-EM3.31EGF-bound EGFR/HER2 ECD complex
8HGPCryo-EM4.53EREG-bound EGFR/HER2 ECD complex
8JYQX-RAY1.75H2Mab-214 with epitope peptide
8JYRX-RAY1.69H2Mab-119 with HER2 domain I
8PWHCryo-EM3.17HER2-Trastuzumab-Pertuzumab complex
8Q6JCryo-EM3.30HER2-Trastuzumab-Pertuzumab complex
8U4KCryo-EM4.27HER2/HER4/BTC heterodimer ECD
8U4LCryo-EM3.31HER2/HER4/NRG1b heterodimer ECD
8U8XX-RAY1.69HER2 YVMA mutant kinase with compound 27
8VB5X-RAY1.48HER2 exon 20 insertion mutant with tucatinib
8VQDCryo-EM2.61HER2 S310F with TL1 Fab
8VQECryo-EM2.67HER2 S310F homodimer ECD
9IUTX-RAY2.09H2Mab-250 with epitope peptide
9L1SCryo-EM3.00HER2 S310F-pertuzumab complex
9MTECryo-EM2.66HER2 ECD with nanobodies 27A05 & 47D05
9MTXCryo-EM3.06HER2 ECD with nanobody 29E09
9QBFCryo-EM3.80HER2 ECD compact form with trastuzumab
9QBGCryo-EM3.60HER2 ECD extended form with trastuzumab
9QBHCryo-EM3.77HER2 ECD full-length in amphipols
Method Summary: 41 X-RAY, 7 NMR, 13 Cryo-EM AlphaFold Predicted Structure
AlphaFold IDGlobal pLDDTSequence LengthFraction Very High Confidence
P0462674.6596610.43 (43%)

Section 5: Cross-Species Orthologs

SpeciesGene IDSymbolBiotype
Mouse (Mus musculus)ENSMUSG00000062312Erbb2protein_coding
Rat (Rattus norvegicus)ENSRNOG00000006450Erbb2protein_coding
Zebrafish (Danio rerio)ENSDARG00000026294erbb2protein_coding
Fruit fly (D. melanogaster)No direct ortholog-ERBB family absent
Worm (C. elegans)No direct ortholog-ERBB family absent
Yeast (S. cerevisiae)No ortholog-RTK family absent
Note: ERBB2 is a vertebrate-specific receptor tyrosine kinase; invertebrates lack this gene family.

Section 6: Clinical Variants & AI Predictions ClinVar Clinical Variants Total Variants in ClinVar: 803 Classification Breakdown (from sampled data):

ClassificationCount (sample)
Pathogenic1
Likely pathogenic0
Uncertain significance (VUS)~30
Likely benign~50
Benign~15
Conflicting1
Not provided~8
TOP 50 Pathogenic/Likely Pathogenic Variants
Variant IDHGVSClassificationCondition
1188812NM_004448.4(ERBB2):c.2129C>T (p.Ala710Val)PathogenicCancer predisposition
Note: Most ERBB2 variants in ClinVar are somatic (cancer-related) rather than germline pathogenic variants. The majority are classified as VUS or benign. AlphaMissense AI Predictions Total Missense Predictions: 8,156 TOP 50 Predicted Pathogenic Missense Variants (sample):
PositionVariantAM ScoreClass
17:39700266G10R0.495ambiguous
17:39700263W9R0.381ambiguous
17:39700279A14D0.367ambiguous
17:39700267G10E0.314likely_benign
Note: Most signal peptide and early N-terminal variants are predicted as likely_benign, consistent with their location outside functional domains. SpliceAI Splice Effect Predictions Total Splice Predictions: 4,562 TOP 50 High-Impact Splice-Altering Variants:
VariantEffectDelta Score
17:39700308:CAAGG>Cdonor_loss0.99
17:39700309:AAGGT>Adonor_loss0.99
17:39700310:AGGT>Adonor_loss0.99
17:39700313:T>Adonor_loss0.99
17:39701847:G>GTdonor_gain0.99
17:39700230:G>GGdonor_gain0.97
17:39700454:G>Tdonor_gain0.96
17:39700229:A>AGdonor_gain0.94
17:39701847:G>Tdonor_gain0.94
17:39700312:G>GGdonor_gain0.90
17:39700572:G>GTdonor_gain0.90
17:39700426:G>GTdonor_gain0.88
17:39700235:C>Tdonor_gain0.83
17:39700310:AGGTG>Adonor_gain0.82
17:39700611:G>GTdonor_gain0.82

Section 7: Biological Pathways & Gene Ontology Reactome Pathways Total Pathways: 33

Pathway IDNameDisease Pathway
R-HSA-1227986Signaling by ERBB2No
R-HSA-1250196SHC1 events in ERBB2 signalingNo
R-HSA-1251932PLCG1 events in ERBB2 signalingNo
R-HSA-1257604PIP3 activates AKT signalingNo
R-HSA-1306955GRB7 events in ERBB2 signalingNo
R-HSA-1358803Downregulation of ERBB2:ERBB3 signalingNo
R-HSA-1963640GRB2 events in ERBB2 signalingNo
R-HSA-1963642PI3K events in ERBB2 signalingNo
R-HSA-2219530Constitutive Signaling by Aberrant PI3K in CancerYes
R-HSA-416572Sema4D induced cell migration and growth-cone collapseNo
R-HSA-5673001RAF/MAP kinase cascadeNo
R-HSA-6785631ERBB2 Regulates Cell MotilityNo
R-HSA-6811558PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingNo
R-HSA-8847993ERBB2 Activates PTK6 SignalingNo
R-HSA-8863795Downregulation of ERBB2 signalingNo
R-HSA-8866910TFAP2 family regulates transcription of GFs and receptorsNo
R-HSA-9634285Constitutive Signaling by Overexpressed ERBB2Yes
R-HSA-9652282Drug-mediated inhibition of ERBB2 signalingNo
R-HSA-9664565Signaling by ERBB2 KD MutantsYes
R-HSA-9665233Resistance of ERBB2 KD mutants to trastuzumabYes
R-HSA-9665244Resistance of ERBB2 KD mutants to sapitinibYes
R-HSA-9665245Resistance of ERBB2 KD mutants to tesevatinibYes
R-HSA-9665246Resistance of ERBB2 KD mutants to neratinibYes
R-HSA-9665247Resistance of ERBB2 KD mutants to osimertinibYes
R-HSA-9665249Resistance of ERBB2 KD mutants to afatinibYes
R-HSA-9665250Resistance of ERBB2 KD mutants to AEE788Yes
R-HSA-9665251Resistance of ERBB2 KD mutants to lapatinibYes
R-HSA-9665348Signaling by ERBB2 ECD mutantsYes
R-HSA-9665686Signaling by ERBB2 TMD/JMD mutantsYes
R-HSA-9665737Drug resistance in ERBB2 TMD/JMD mutantsYes
R-HSA-9927418Developmental Lineage of Mammary Gland Luminal Epithelial CellsNo
R-HSA-9927432Developmental Lineage of Mammary Gland Myoepithelial CellsNo
R-HSA-9938206Developmental Lineage of Mammary Stem CellsNo
Gene Ontology Annotations Total GO Terms: 69 Biological Process (BP) - Count: 40
GO IDTerm
GO:0006468protein phosphorylation
GO:0007165signal transduction
GO:0007166cell surface receptor signaling pathway
GO:0007167enzyme-linked receptor protein signaling pathway
GO:0007169cell surface receptor protein tyrosine kinase signaling pathway
GO:0007173epidermal growth factor receptor signaling pathway
GO:0007507heart development
GO:0007528neuromuscular junction development
GO:0008045motor neuron axon guidance
GO:0008283cell population proliferation
GO:0014044Schwann cell development
GO:0018108peptidyl-tyrosine phosphorylation
GO:0030182neuron differentiation
GO:0030307positive regulation of cell growth
GO:0032886regulation of microtubule-based process
GO:0033080immature T cell proliferation in thymus
GO:0033088negative regulation of immature T cell proliferation in thymus
GO:0035025positive regulation of Rho protein signal transduction
GO:0035556intracellular signal transduction
GO:0038133ERBB2-ERBB3 signaling pathway
GO:0038134ERBB2-EGFR signaling pathway
GO:0038135ERBB2-ERBB4 signaling pathway
GO:0042060wound healing
GO:0042552myelination
GO:0043066negative regulation of apoptotic process
GO:0043406positive regulation of MAP kinase activity
GO:0043410positive regulation of MAPK cascade
GO:0043491PI3K/AKT signal transduction
GO:0045727positive regulation of translation
GO:0045765regulation of angiogenesis
GO:0045785positive regulation of cell adhesion
GO:0045943positive regulation of transcription by RNA polymerase I
GO:0048709oligodendrocyte differentiation
GO:0050679positive regulation of epithelial cell proliferation
GO:0070372regulation of ERK1 and ERK2 cascade
GO:0071363cellular response to growth factor stimulus
GO:0071364cellular response to epidermal growth factor stimulus
GO:0071526semaphorin-plexin signaling pathway
GO:0090314positive regulation of protein targeting to membrane
GO:0099645neurotransmitter receptor localization to postsynaptic membrane
Molecular Function (MF) - Count: 12
GO IDTerm
GO:0001042RNA polymerase I core binding
GO:0004713protein tyrosine kinase activity
GO:0004714transmembrane receptor protein tyrosine kinase activity
GO:0004888transmembrane signaling receptor activity
GO:0005102signaling receptor binding
GO:0005524ATP binding
GO:0015026coreceptor activity
GO:0030971receptor tyrosine kinase binding
GO:0042802identical protein binding
GO:0043125ErbB-3 class receptor binding
GO:0046982protein heterodimerization activity
Cellular Component (CC) - Count: 17
GO IDTerm
GO:0002116semaphorin receptor complex
GO:0005634nucleus
GO:0005654nucleoplasm
GO:0005769early endosome
GO:0005829cytosol
GO:0005886plasma membrane
GO:0009925basal plasma membrane
GO:0010008endosome membrane
GO:0016020membrane
GO:0016323basolateral plasma membrane
GO:0016324apical plasma membrane
GO:0031594neuromuscular junction
GO:0032587ruffle membrane
GO:0038143ERBB3:ERBB2 complex
GO:0042734presynaptic membrane
GO:0043209myelin sheath
GO:0043235receptor complex
GO:0048471perinuclear region of cytoplasm

Section 8: Protein Interactions & Molecular Networks STRING Protein-Protein Interactions Total Interactions: 7,626 TOP 50 Highest-Confidence Interacting Proteins:

PartnerScoreGene Name
P04626998ERBB2 (homodimer)
P01133998EGF
P98202998ERBB3
P29354994SRC
Q96RT1993ERBB2IP
Q99102993MUC4
P16070992CD44
P29353992SHC1
Q14451990GRB7
P07900985HSP90AA1
P21860984ERBB3
P00533983EGFR
P08238983HSP90AB1
Q15303983ERBB4
P08069980IGF1R
P12931980SRC
P01135978TGFA
P06401972PGR
P03372966ESR1
P12830964CDH1
P13931958PLCG1
P35222955CTNNB1
P19474945TRIM21
P16144939ITGB4
O14511930NRG2
O43157929PLXNB1
P42336927PIK3CA
P01343926IGF2
P04637924TP53
P01116923KRAS
P16422921EPCAM
P38398919BRCA1
Q99075911HBEGF
P02570909ACTB
P15514888AREG
P12314879FCGR1A
P34932877HSPA4
P51587874BRCA2
P01106870MYC
P60484864PTEN
P24385863CCND1
P50616853AKT1
Q9UNE7849STUB1
P10415848BCL2
Q14627847IL13RA2
P08637839FCGR3A
Q14152832EIF3A
Q12955825ANK3
P40763824STAT3
Q01484824ANK2
IntAct Molecular Interactions Total IntAct Interactions: 820+ Key Interaction Partners:
  • ERBB2-ERBB2 homodimer (score: 0.93)
  • ERBB2-EGFR heterodimer (score: 0.95)
  • ERBB2-ERBB3 heterodimer (score: 0.97)
  • ERBB2-ERBB4 heterodimer (score: 0.82)
  • ERBB2-SHC1 (score: 0.82)
  • ERBB2-HSP90AA1 (score: 0.86)
  • ERBB2-PTPN11 (score: 0.68) Protein Similarity ESM2 Structural/Embedding Similarity Total Similar Proteins: 43 TOP 20 Structurally Similar Proteins:
UniProtTop SimilarityAvg Similarity
P21860 (ERBB3)1.00000.9642
Q5RB22 (ERBB3, Pongo)1.00000.9642
P00533 (EGFR)0.99990.9530
P55245 (ERBB3, Rat)0.99990.9535
Q61526 (ERBB3, Mouse)0.99990.9652
Q62799 (ERBB3, Rat)0.99990.9653
Q13445 (ERBB4)0.99990.9408
Q5R7E6 (ERBB4, Pongo)0.99990.9405
Q9ESM2 (ERBB4)0.99970.9315
Q9ESM3 (ERBB4)0.99970.9319
Q3V0090.99960.9419
Q5BK850.99960.9420
O55058 (Erbb2, Mouse)0.99950.9444
P06494 (Erbb2, Chicken)0.99950.9598
P079420.99950.9439
P70424 (Erbb2, Rat)0.99950.9603
Q4V7F20.99940.9439
Q91XD70.99940.9456
Q012790.99930.9539
Q60553 (Erbb2, Mouse)0.99920.9615
DIAMOND Sequence Similarity Total Homologous Proteins: 47 TOP 20 Sequence-Similar Proteins:
UniProtIdentity (%)Bitscore
P00534 (EGFR, Chicken)100.01210
P00535 (EGFR, Human)99.51211
P11273100.01062
P00533 (EGFR)99.32440
P55245 (ERBB3)99.32437
Q61527 (ERBB4)98.82628
Q6295698.82631
P7060098.31986
Q9QVP998.31985
P21860 (ERBB3)98.02625
Q5RB2298.02627
Q6472597.31267
P4802597.31268
Q15303 (ERBB4)97.32605
Q61526 (Erbb3, Mouse)96.72553
Q62799 (Erbb3, Rat)96.72551
O5496795.91963
Q5U2X595.91962
Q1428995.61930
P06494 (Erbb2, Chicken)94.92473

Section 9: Transcription Factor Regulatory Data Note: ERBB2 is NOT a transcription factor. This section documents TFs that regulate ERBB2. Upstream Regulators (TFs that regulate ERBB2) Total Regulatory Relationships: 73

TF GeneRegulation TypeConfidence
ARActivationHigh
ESR1ActivationHigh
ETS1ActivationHigh
JUNActivationHigh
NCOA1ActivationHigh
RBPJActivationHigh
SP1ActivationLow
SP3Activation-
SP4Activation-
YBX1ActivationHigh
YY1ActivationHigh
NOTCH1Activation-
DTX1Activation-
GATA5Activation-
FOXM1ActivationLow
MYCRepressionHigh
TBPRepressionHigh
GATA4RepressionHigh
ETV4RepressionHigh
PGRRepression-
MYBL2RepressionLow
DENND4ARepression-
EGR2-High
ELF1UnknownHigh
ELF3-High
ENO1-High
FOXP3UnknownHigh
GLI3-High
HIF1A-Low
HSF1-High
MYBUnknownHigh
NCOA3UnknownHigh
NFE2L2-High
NFKB-High
NRG1-High
PARP1-High
PAX2UnknownHigh
PURAUnknownHigh
TCF3-High
TFAP2AUnknownHigh
TFAP2BUnknownHigh
TFAP2CUnknownHigh
TP53-High
TP63-High
TTF1-High
Downstream Targets (Genes regulated BY ERBB2 signaling) From CollecTRI data, ERBB2 regulates:
Target GeneRegulation Type
MSI1Activation
NOTCH3Activation

Section 10: Drug & Pharmacology Data ChEMBL Target Information

Target IDNameType
CHEMBL1824Receptor tyrosine-protein kinase erbB-2SINGLE PROTEIN
CHEMBL2111431EGFR and ErbB2 (HER1/HER2)PROTEIN FAMILY
CHEMBL2363049Epidermal growth factor receptorPROTEIN FAMILY
CHEMBL4106134FASN/HER2PROTEIN COMPLEX
CHEMBL4630723ErbB-2/ErbB-3 heterodimerPROTEIN COMPLEX
CHEMBL5465227VHL/ERBB2PROTEIN-PROTEIN INTERACTION
Approved Drugs (Phase 4) Targeting ERBB2 Total Approved Drugs: 41
ChEMBL IDDrug NameType
CHEMBL554LAPATINIBSmall molecule
CHEMBL1201179LAPATINIB DITOSYLATESmall molecule
CHEMBL1173655AFATINIBSmall molecule
CHEMBL2105712AFATINIB DIMALEATESmall molecule
CHEMBL180022NERATINIBSmall molecule
CHEMBL3989868TUCATINIBSmall molecule
CHEMBL2105719DACOMITINIBSmall molecule
CHEMBL2110732DACOMITINIB ANHYDROUSSmall molecule
CHEMBL553ERLOTINIBSmall molecule
CHEMBL1079742ERLOTINIB HYDROCHLORIDESmall molecule
CHEMBL939GEFITINIBSmall molecule
CHEMBL3353410OSIMERTINIBSmall molecule
CHEMBL1171837PONATINIBSmall molecule
CHEMBL941IMATINIBSmall molecule
CHEMBL5416410DASATINIBSmall molecule
CHEMBL288441BOSUTINIBSmall molecule
CHEMBL1873475IBRUTINIBSmall molecule
CHEMBL3707348ACALABRUTINIBSmall molecule
CHEMBL3936761ZANUBRUTINIBSmall molecule
CHEMBL4071161TIRABRUTINIBSmall molecule
CHEMBL3545311BRIGATINIBSmall molecule
CHEMBL2105717CABOZANTINIBSmall molecule
CHEMBL24828VANDETANIBSmall molecule
CHEMBL4558324LAZERTINIBSmall molecule
CHEMBL1336SORAFENIBSmall molecule
CHEMBL428647PACLITAXELSmall molecule
CHEMBL53463DOXORUBICINSmall molecule
CHEMBL58MITOXANTRONESmall molecule
CHEMBL83TAMOXIFENSmall molecule
CHEMBL633AMIODARONESmall molecule
CHEMBL71CHLORPROMAZINESmall molecule
CHEMBL726FLUPHENAZINESmall molecule
CHEMBL104CLOTRIMAZOLESmall molecule
CHEMBL808ECONAZOLESmall molecule
CHEMBL91MICONAZOLESmall molecule
CHEMBL496HEXACHLOROPHENESmall molecule
CHEMBL24944TRIBROMSALANSmall molecule
CHEMBL290106BITHIONOLSmall molecule
CHEMBL296419ASTEMIZOLESmall molecule
CHEMBL305660EBASTINESmall molecule
CHEMBL6067481COLISTINUnknown
SIGNOR Signaling Interactions (Drug-Target) Key Inhibitors with Mechanisms:
DrugEffectMechanismDirect
Lapatinibdown-regulateschemical inhibitionYes
Afatinibdown-regulateschemical inhibitionYes
Neratinibdown-regulateschemical inhibitionYes
Tucatinibdown-regulateschemical inhibitionYes
Dacomitinibdown-regulateschemical inhibitionYes
Sapitinibdown-regulateschemical inhibitionYes
Canertinibdown-regulateschemical inhibitionYes
Trastuzumabdown-regulates activitybindingYes
Pertuzumabdown-regulates activitybindingYes
Ado-trastuzumab emtansinedown-regulates activitybindingYes
PharmGKB Pharmacogenomics
PharmGKB IDSymbolVIP GeneCPIC Guideline
PA27844ERBB2YesNo
Alternate Names: human epidermal growth factor receptor 2, metastatic lymph node gene 19, neuro/glioblastoma derived oncogene homolog BindingDB Drug-Target Binding Data Total Binding Assays: 4,477+ Representative high-affinity compounds with nanomolar binding.

Section 11: Expression Profiles Bgee Expression Summary

AttributeValue
Expression BreadthUbiquitous
Total Present Calls276
Total Absent Calls21
Total Conditions297
Max Expression Score97.71
Average Expression Score83.42
Gold Quality Count275
TOP 30 Tissues by Expression Score
Tissue (UBERON)Expression ScoreQuality
Lower esophagus mucosa (UBERON:0035834)97.71Gold
Right uterine tube (UBERON:0001302)97.26Gold
Sural nerve (UBERON:0015488)96.73Gold
Skin of leg (UBERON:0001511)96.65Gold
Metanephros cortex (UBERON:0010533)96.57Gold
Esophagus mucosa (UBERON:0002469)96.57Gold
Skin of abdomen (UBERON:0001416)96.50Gold
Tibial nerve (UBERON:0001323)96.39Gold
Nerve (UBERON:0001021)96.39Gold
Renal medulla (UBERON:0000362)96.35Gold
Minor salivary gland (UBERON:0001830)96.10Gold
Right lobe of thyroid gland (UBERON:0001119)96.09Gold
Olfactory segment of nasal mucosa (UBERON:0005386)96.02Gold
Mucosa of transverse colon (UBERON:0004991)95.99Gold
Left lobe of thyroid gland (UBERON:0001120)95.86Gold
Zone of skin (UBERON:0000014)95.48Gold
Descending thoracic aorta (UBERON:0002345)95.36Gold
Thyroid gland (UBERON:0002046)95.30Gold
Mouth mucosa (UBERON:0003729)95.08Gold
Right atrium auricular region (UBERON:0006631)94.99Gold
Saliva-secreting gland (UBERON:0001044)94.76Gold
Transverse colon (UBERON:0001157)94.60Gold
Rectum (UBERON:0001052)94.58Gold
Thoracic aorta (UBERON:0001515)94.55Gold
Ascending aorta (UBERON:0001496)94.45Gold
Ventricular zone (UBERON:0003053)94.34Gold
Adult mammalian kidney (UBERON:0000082)94.22Gold
Aorta (UBERON:0000947)93.98Gold
Epithelium of bronchus (UBERON:0002031)93.98Gold
Apex of heart (UBERON:0002098)93.96Gold
Single-Cell Expression Experiments (Single Cell Expression Atlas) Total Experiments: 5
Experiment IDDescriptionSpeciesCells
E-CURD-53SARS-CoV-1/2 infected human cell linesHomo sapiens187,349
E-GEOD-75688Primary breast cancer cells (4 subtypes: luminal A/B, HER2, TNBC)Homo sapiens549
E-MTAB-10018Naive and primed hPSCs with SB431542Homo sapiens37,007
E-MTAB-6379T lymphocytes from H7N9 patientsHomo sapiens119
E-MTAB-6819Naive and primed hESCsHomo sapiens1,344

Section 12: Disease Associations OMIM Disease Associations

OMIM IDDisease
164870ERBB2 gene locus
137800Glioma susceptibility 1
167000Ovarian cancer
211980Lung cancer
613659Gastric cancer
619465Visceral neuropathy, familial, 2, autosomal recessive
GenCC Gene-Disease Validity
DiseaseOMIMClassificationMOISubmitter
Lung cancer211980LimitedADAmbry Genetics
Glioma susceptibility 1137800LimitedUnknownLabcorp Genetics
Visceral neuropathy, familial, 2, AR619465LimitedUnknownLabcorp Genetics
Hirschsprung disease388SupportiveADOrphanet
Orphanet Rare Disease Associations Total Orphanet Diseases: 4
Orphanet IDDisease NameTypeGene Count
213726Serous carcinoma of the corpus uteriDisease1
2800Extramammary Paget diseaseDisease1
388Hirschsprung diseaseDisease14
99976Adenocarcinoma of esophagus/esophagogastric junctionDisease1
HPO Phenotype Associations Total HPO Terms: 49
HPO IDPhenotype
HP:0003002Breast carcinoma
HP:0030078Lung adenocarcinoma
HP:0030358Non-small cell lung carcinoma
HP:0006519Alveolar cell carcinoma
HP:0012126Stomach cancer
HP:0011459Esophageal carcinoma
HP:0100580Barrett esophagus
HP:0006774Ovarian papillary adenocarcinoma
HP:0002888Ependymoma
HP:0009592Astrocytoma
HP:0012174Glioblastoma multiforme
HP:0100621Dysgerminoma
HP:0002251Aganglionic megacolon
HP:0011284Short-segment aganglionic megacolon
HP:0005214Intestinal obstruction
HP:0004387Enterocolitis
HP:0031369Colon perforation
HP:0002014Diarrhea
HP:0002019Constipation
HP:0012450Chronic constipation
HP:0002020Gastroesophageal reflux
HP:0002027Abdominal pain
HP:0003270Abdominal distention
HP:0002017Nausea and vomiting
HP:0034754Bilious emesis
HP:6000224Delayed passage of meconium
HP:0012719Functional abnormality of GI tract
HP:0003477Peripheral axonal neuropathy
HP:0000407Sensorineural hearing impairment
HP:0000508Ptosis
HP:0001510Growth delay
HP:0001513Obesity
HP:0004322Short stature
HP:0001531Failure to thrive in infancy
HP:0011968Feeding difficulties
HP:0008872Feeding difficulties in infancy
HP:0001824Weight loss
HP:0001561Polyhydramnios
HP:0001762Talipes equinovarus
HP:0001864Clinodactyly of the 5th toe
HP:0002716Lymphadenopathy
HP:0012735Cough
HP:0100749Chest pain
HP:0100806Sepsis
HP:0410067Increased level of L-fucose in urine
HP:0000006Autosomal dominant inheritance
HP:0000007Autosomal recessive inheritance
HP:0003593Infantile onset
HP:0001442Typified by somatic mosaicism
GWAS Associations Total GWAS Associations: 17
Study IDTraitp-valueMapped Gene
GCST005212Asthma2×10⁻³⁰ERBB2
GCST008747Estimated GFR8×10⁻²⁹ERBB2
GCST010002Refractive error1×10⁻²⁴CDK12
GCST007564Asthma/allergic disease4×10⁻¹⁷GSDMB
GCST008916Asthma2×10⁻⁶²GSDMB
GCST008916Asthma2×10⁻¹⁴MED1
GCST005752Systemic lupus erythematosus2×10⁻¹²ERBB2, MIEN1
GCST007266Adult asthma4×10⁻¹²IKZF3
GCST008916Asthma3×10⁻¹⁰FBXL20
GCST008916Asthma5×10⁻⁹STARD3
GCST003155Systemic lupus erythematosus8×10⁻⁹IKZF3
GCST003724Bipolar disorder5×10⁻⁹ERBB2, PGAP3
GCST000624Ulcerative colitis3×10⁻⁸GSDMB
GCST012465Bipolar disorder2×10⁻⁸THRA
GCST012465Bipolar disorder3×10⁻⁸GSDMA
GCST003144Polycystic ovary syndrome1×10⁻⁶CDK12-NEUROD2
GCST007235Pancreatic ductal adenocarcinoma1×10⁻⁶PNMT

DATA SOURCES

DatabaseCount/Usage
HGNCGene symbol, aliases
EnsemblGene, 34 transcripts, 27 exons
NCBI EntrezGene ID, summary
OMIM6 disease entries
UniProt11 protein entries
RefSeq31 mRNA, 31 protein
CCDS6 entries
PDB61 structures
AlphaFold1 predicted model
InterPro15 domains/families
ClinVar803 variants
AlphaMissense8,156 predictions
SpliceAI4,562 predictions
Reactome33 pathways
GO69 annotations
STRING7,626 interactions
IntAct820+ interactions
ChEMBL41 approved drugs
BindingDB4,477+ assays
PharmGKBVIP gene
SIGNOR98 signaling relations
CollecTRI73 TF regulations
Bgee276 tissue expression calls
SCXA5 single-cell experiments
HPO49 phenotype terms
GWAS Catalog17 associations
GenCC4 gene-disease validations
Orphanet4 rare diseases

Reference compiled from Biobtree integrated database. Data current as of query date. I’ve compiled a comprehensive cross-database identifier and functional mapping reference for human ERBB2 (HER2). The document includes all 12 requested sections with: Summary of Key Identifiers:

  • HGNC: HGNC:3430
  • Ensembl: ENSG00000141736
  • Entrez: 2064
  • OMIM: 164870
  • UniProt (canonical): P04626
  • RefSeq MANE Select: NM_004448 / NP_004439
  • Location: Chr17:39,687,914-39,730,426 (+) Key Statistics:
CategoryCount
Ensembl Transcripts34
RefSeq mRNAs31
UniProt Entries11
PDB Structures61
ClinVar Variants803
AlphaMissense Predictions8,156
SpliceAI Predictions4,562
Reactome Pathways33
GO Annotations69
STRING Interactions7,626
Approved Drugs41
GWAS Associations17
HPO Phenotypes49
ERBB2 is a critical oncogene with extensive structural data (61 PDB structures), numerous approved targeted therapies (lapatinib, afatinib, neratinib, tucatinib, trastuzumab, pertuzumab), and associations with breast cancer, lung cancer, gastric cancer, and other malignancies.